Application

19405201 · TREATING CANCERS WITH COMBINATIONS OF ANTI-CD20 ANTIBODY AND ACYLFULVENES

Filed 2025-12-01 · Pending The official file ↗ · Art unit OPAP · Examiner Docket Central Easy · CPC A61K 31/17 · Lantern Pharma Inc. · Lantern Pharma Inc.

Office actions

first was

RCEs

no appeal

To first action

n/a

to disposition n/a

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.